FTC Files Lawsuit Against Hims & Hers Health
Hims & Hers Health (NYSE: HIMS) experienced a decline in its stock price following a lawsuit filed by the U.S. Federal Trade Commission, along with Los Angeles County and the Utah Department of Commerce. The suit alleges that the telehealth company violated consumer protection laws. The legal action is part of growing regulatory scrutiny over digital health companies' marketing practices and claims about their products. Hims & Hers has faced previous criticism for its advertising strategies related to skincare, hair loss treatments, and sexual wellness products. This lawsuit could result in significant financial penalties or operational changes if the allegations are proven true.
Tickers: $HIMS
Topics: FTC lawsuit stock movement telehealth